WorldCare Clinical Implements MCC's Imaging Performance Metrics In Support Of Standardized Peformance For Imaging Trials

Main Category: Pharma Industry / Biotech Industry
Also Included In: Clinical Trials / Drug Trials
Article Date: 23 Jun 2009 - 4:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:not yet rated


45th DIA Annual Meeting -- Booth # 1501 -- WorldCare Clinical, LLC (WCC), a leading imaging CRO for clinical trials in the pharmaceutical, biotechnology and medical device industries, announced that it is offering version 1.0 of the Metrics Champion Consortium (MCC) Imaging Performance Metrics to all sponsors' imaging trials beginning July 1, 2009, through its WorldPro™ technology solution.

"We are pleased to announce that WCC is implementing the MCC Imaging Performance Metrics," said Dr. Asli Memisoglu, director of biostatistics and data management at WCC. "Through our innovative WorldPro technology platform, WCC is committed to support industry-wide acceptance of MCC's performance metrics to help ensure best outcomes for our sponsors."

The MCC Imaging Performance Metrics Work Group is a non-profit organization made up of biotechnology, pharmaceutical and service provider organizations that work collaboratively to develop and implement standardized performance metrics aimed at improving the efficiency and effectiveness of managing and tracking resources needed to successfully run clinical trials.

Additionally, WCC will offer statistical analysis of reader reliability, with metrics such as kappa and correlation coefficients, to evaluate reader performance and reliability. "It is critical for a study's success to have a high level of agreement across readers and good consistency within assessments made by the same reader," said Dr. Richard Walovitch, chief medical officer at WCC. "WCC provides the results from these ongoing evaluations to the client and the reading team in the form of a study newsletter, which helps to facilitate communication of case studies, reader performance, and operational metrics."

WCC representatives will be available at Booth # 1501 during this week's DIA Annual Meeting in San Diego, California, to discuss its application of the MCC and other metrics in imaging trials. For more information or to schedule an appointment, contact Vanessa Conde at (978) 406-5518 or vconde@wcclinical.com.

Source
WorldCare Clinical

Article adapted by Medical News Today from original press release.
Visit our pharma industry / biotech industry section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
WorldCare Clinical. "WorldCare Clinical Implements MCC's Imaging Performance Metrics In Support Of Standardized Peformance For Imaging Trials." Medical News Today. MediLexicon, Intl., 23 Jun. 2009. Web.
11 Feb. 2012. <http://www.medicalnewstoday.com/releases/154978.php>

APA
WorldCare Clinical. (2009, June 23). "WorldCare Clinical Implements MCC's Imaging Performance Metrics In Support Of Standardized Peformance For Imaging Trials." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/154978.php.

Please note: If no author information is provided, the source is cited instead.


Pharma Industry / Biotech Industry

Most Popular Articles



Follow Our Pharma Industry News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Pharma Industry / Biotech Industry Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »